Can a smartphone app ease suffering for advanced cancer patients?
NCT ID NCT04989556
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 37 times
Summary
This study tests whether a technology-enhanced symptom monitoring program, used alongside standard in-person and remote palliative care, can improve quality of life for 119 adults with advanced solid tumors who are also in phase I immunotherapy trials. Participants use the program to report symptoms, and researchers track changes in distress and satisfaction. The goal is to see if adding digital tools makes palliative care more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
technology-enhanced symptom monitoring program
What this could lead to
If it works, this could show that adding a digital symptom tracker to standard palliative care improves quality of life for people with advanced cancer.
What could go wrong
This is a small, early-stage study with only 119 participants, so results may not apply to everyone. The intervention is supportive, not curative, so it won't change the cancer itself.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.